Skip to main content

Want a detailed portfolio tracker?

CDT Equity (CDT) P/E (2023 - 2026)

CDT Equity (CDT) P/E from Sep 25, 2023 to Jun 3, 2026. The TTM CDT Equity (CDT) P/E is -0.02. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of CDT Equity (CDT)

YearP/EChange
2026-0.02-97.48%
2025-0.72-100.00%
202426.40K-98.49%
20231.75MN/A

Comparison CDT Equity (CDT) P/E with competitors

CDT Equity (CDT) P/E is -0.02.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-109.42%
NBYStablecoin Development Corp0.10-666.60%
ENLVEnlivex Therapeutics Ltd0.15-932.53%
FGENFibroGen Inc0.24-1430.45%
TRAWTraws Pharma Inc0.47-2720.63%
FBIOFortress Biotech Inc0.71-4013.21%
CHRSCoherus Biosciences Inc0.98-5521.40%
ORMPOramed Pharmaceuticals Inc1.47-8266.74%
AGENAgenus Inc2.05-11453.84%
VIVSVivoSim Labs Inc2.54-14154.84%
INVAInnoviva Inc3.19-17772.62%
CRMDCorMedix Inc3.65-20306.78%
ABEOAbeona Therapeutics Inc4.20-23406.86%
VXRTVaxart Inc4.26-23720.58%
CVACCureVac N.V.4.45-24740.45%
SRPTSarepta Therapeutics Inc4.62-25730.40%
GLPGGalapagos NV4.86-27030.73%
RIGLRigel Pharmaceuticals4.92-27367.18%
ZVRAZevra Therapeutics Inc4.97-27669.26%
ABUSArbutus Biopharma Corp5.69-31658.41%
CGENCompugen Ltd7.38-41026.82%
AUPHAurinia Pharmaceuticals Inc9.25-51377.98%
ACADAcadia Pharmaceuticals Inc9.59-53243.68%
OMEROmeros Corporation9.88-54881.02%
PLXProtalix BioTherapeutics Inc9.91-55023.47%
SPROSpero Therapeutics Inc10.73-59599.59%
ADMAAdma Biologics Inc11.33-62902.54%
SVASinovac Biotech Ltd11.44-63486.75%
TBPHTheravance Biopharma Inc11.78-65374.62%
HRMYHarmony Biosciences Holdings Inc12.18-67612.80%
TGTXTG Therapeutics Inc13.18-73150.04%
INCYIncyte Corp13.38-74273.01%
SABSSAB Biotherapeutics Inc14.06-78018.27%
XOMAXOMA Corp14.95-82937.49%
REGNRegeneron Pharmaceuticals Inc14.98-83131.49%
PBYIPuma Biotechnology Inc15.05-83520.59%
EXELExelixis Inc15.79-87646.64%
NAGENiagen Bioscience Inc16.35-90751.16%
CPRXCatalyst Pharmaceuticals Inc17.34-96237.40%
MDXGMimedx Group Inc17.38-96407.01%
ARGXArgen X SE23.07-127979.83%
HALOHalozyme Therapeutics Inc23.20-128694.85%
XOMAOXOMA Corp25.34-140579.69%
VRTXVertex Pharmaceuticals Inc25.66-142303.50%
XOMAPXOMA Corp25.67-142382.76%
CTMXCytomX Therapeutics Inc25.70-142536.85%
ASNDAscendis Pharma A/S26.35-146174.03%
RPRXRoyalty Pharma plc - Class A27.50-152500.01%
SLNOSoleno Therapeutics Inc29.02-160924.49%
LGNDLigand Pharmaceuticals Inc - Class B30.19-167416.20%
BMRNBiomarin Pharmaceutical Inc37.51-207993.27%
APLSApellis Pharmaceuticals Inc39.02-216384.50%
KRYSKrystal Biotech Inc39.70-220133.64%
GMABGenmab40.20-222938.29%
ONCBeiGene Ltd67.03-371613.54%
TECHBio-Techne Corp68.59-380305.18%
VCELVericel Corp80.63-447007.62%
PHARPharming Group N.V.87.74-486421.82%
ALNYAlnylam Pharmaceuticals Inc124.93-692576.32%
TLXTelix Pharmaceuticals Ltd139.89-775479.21%
CORTCorcept Therapeutics Inc158.39-878012.44%